(Q41665530)

6 October 2017

0 references

Interferon therapy for acute hepatitis C viral infection--a review by meta-analysis (English)

1 reference

6 October 2017

Quin JW

1

1 reference

6 October 2017

publication date

1 October 1997

1 reference

Australian and New Zealand journal of medicine

6 October 2017

published in

1 reference

6 October 2017

volume

27

1 reference

6 October 2017

issue

5

1 reference

6 October 2017

page(s)

611-7; discussion 617-8

1 reference

Outbreak of acute hepatitis C following the use of anti-hepatitis C virus--screened intravenous immunoglobulin therapy.

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Acute hepatitis C infection in patients undergoing therapy for haematological malignancies: a clinical and virological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

High-dose interferon-alpha2b treatment prevents chronicity in acute hepatitis C: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Acute hepatitis C infection after sexual exposure.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

The treatment of chronic viral hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Interferon as treatment for acute hepatitis C. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Multicentre randomised controlled trial of recombinant interferon alfa-2b in patients with acute non-A, non-B/type C hepatitis after transfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Recombinant human interferon alfa-2b treatment for acute non-A, non-B hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

A randomized controlled trial of recombinant interferon alpha-2b in the treatment of Chinese patients with acute post-transfusion hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Effects of interferon beta on non-A, non-B acute hepatitis: a prospective, randomized, controlled-dose study. Japan Acute Hepatitis Cooperative Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

Interferon alfa therapy in patients with chronic hepatitis C and persistently normal aminotransferase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1445-5994.1997.TB00985.X

10.1111/J.1445-5994.1997.TB00985.X

21 January 2018

Identifiers

DOI

1 reference

6 October 2017

1 reference